Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IGF2R | P11717 | 4/20 | 0.48 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.44 |
| ▸ | LGALS3 | P17931 | 3/20 | 0.38 |
| ▸ | LGALS8 | O00214 | 2/20 | 0.38 |
| ▸ | LGALS4 | P56470 | 1/20 | 0.38 |
| ▸ | LGALS1 | P09382 | 2/20 | 0.36 |
| ▸ | LGALS9 | O00182 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
| ▸ | TYR | P14679 | 1/20 | 0.34 |
| ▸ | GJA1 | P17302 | 1/20 | 0.34 |
| ▸ | GJB2 | P29033 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5316332 | 1.00 | IGF2R (0.48) | IGF2RSLC2A1LGALS3LGALS8LGALS4 | |
| SCHEMBL20985060 | 1.00 | IGF2R (0.48) | IGF2RSLC2A1LGALS3LGALS8LGALS4 | |
| SCHEMBL5311406 | 1.00 | IGF2R (0.48) | IGF2RSLC2A1LGALS3LGALS8LGALS4 | |
| SCHEMBL6250631 | 1.00 | IGF2R (0.48) | IGF2RSLC2A1LGALS3LGALS8LGALS4 | |
| Hydrochloric Acid SCHEMBL8642711 | 0.98 | IGF2R (0.47) | IGF2RSLC2A1LGALS3LGALS8LGALS4 | |
| SCHEMBL23026281 | 0.95 | SLC2A1 (0.49) | IGF2RSLC2A1LGALS3LGALS8LGALS4 | |
| Acetic Acid SCHEMBL4950224 | 0.91 | IGF2R (0.51) | IGF2RSLC2A1MAPK1 | |
| Acetic Acid SCHEMBL4950523 | 0.91 | IGF2R (0.51) | IGF2RSLC2A1MAPK1 | |
| SCHEMBL16146019 | 0.90 | SLC2A1 (0.49) | IGF2RSLC2A1LGALS3LGALS8LGALS4 | |
| SCHEMBL18725666 | 0.90 | SLC2A1 (0.49) | IGF2RSLC2A1LGALS3LGALS8LGALS4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200368373-A1 | OPTICAL IMAGING AGENTS TARGETING INFLAMMATION | UNIVERSITÉ PARIS CITÉ (FR) | 2020-11-26 | — | — | US | disclosed |
| US-20170299581-A1 | ELECTROCHEMICAL TYROSINASE ENZYME IMMUNOASSAY BIOSENSOR AND SYSTEMS AND METHODS RELATED THERETO | NATIONAL SCIENCE FOUNDATION | 2017-10-19 | — | — | US | disclosed |
| US-8623196-B2 | Nanostructured biosensor containing neuropathy target esterase activity | MICHIGAN STATE UNIVERSITY (US) | 2014-01-07 | — | — | US | disclosed |
| US-20120160708-A1 | Nanostructured Biosensor Containing Neuropathy Target Esterase Activity | THE REGENTS OF THE UNIVERSITY OF MICHIGAN | 2012-06-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200368373-A1 | OPTICAL IMAGING AGENTS TARGETING INFLAMMATION | LGALS1, GALR1, SIGLEC9 | IGF2R 110/4885SLC2A1 1551/4885LGALS3 14/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.